Velpatasvir-Based Regimens in Treatment-Naïve and Treatment-Experienced Adults with Resistant Hepatitis C Virus Genotype 4 Subtypes Endemic to Sub-Saharan Africa: Findings from the SHARED-3 Study in Rwanda - Fabienne Shumbusho

Conference on Liver Disease in Africa (COLDA) 2021

Current Approaches for Identifying and Managing HIV Treatment Failure Among Children, Adolescents, and Young People In Sub- Saharan Africa: Multi-Country Experience from the New Horizons Collaborative - Natella Rakhmanina

INTEREST 2020

Prevalence, Risk and Protective Factors for Common Mental Disorders Among Young People Living With HIV Compared to Their Uninfected Peers From the Kenyan Coast: A Cross Sectional Study - Moses Kachama Nyongesa

INTEREST 2020

Can Treatment For Hepatitis C Virus In Resource-Constrained Settings Improve Case Finding And Control Of Highly Prevalent Chronic Co-Morbidities? Secondary Analysis From The Shared Study In Rwanda - F. Shumbusho

Conference on Liver Disease in Africa (COLDA) 2020

Risky Sexual Behaviors: a Comparative Analysis Between Adolescent Female Sex Workers (AFSW) and Adolescents from the General Population (GP) in Ten Jilinde-Supported Counties in Kenya - Patricia Ong’wen, Kenya

International Workshop on HIV & Adolescence 2019

Social work engagement improves linking newly diagnosed HIV positive children and young adults to ART care: Lessons learnt from the 2019 Namibia Violence against Children and Youth Survey (VACS)

INTEREST 2020

Opportunities for the use of interactive digital interventions to promote sexual health education among youth aged 13-24 years. Lessons from Wadau Youth Self Help Group in Ruaraka. Nairobi, Kenya.

International Workshop on HIV & Adolescence 2019

Weight Change in Females with HIV Switched From 3-Drug Combination Antiretroviral Therapy (Biktarvy Or Genvoya) To, Or Newly Initiated On, 2-Drug Antiretroviral Therapy (Dovato): A Real-World Study

International Workshop on HIV & Women 2021

Abstract: Initial viral load decline and response rates by baseline viral load strata with dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate/emtricitabine: Pooled results from the GEMINI studies (#7) | Michael Aboud

HIV DART and Emerging Viruses 2018

CrAg positivity rates reported from a national CD4-reflexed screening programme identify high-risk regions of co-existent HIV/Cryptococcal disease, requiring urgent programmatic focus into care- L. Coetzee

INTEREST 2017